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Abstract
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and
Food Allergens (NDA) was asked to deliver a scientiﬁc opinion on Yarrowia lipolytica yeast biomass as
a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is the dried and heat-killed biomass
of Yarrowia lipolytica, a yeast species that is widespread in nature and which can be found in the
environment as well as in foods. The production process is sufﬁciently described and does not raise
safety concerns. The information provided on the composition of the NF is sufﬁcient and does not raise
safety concerns. The applicant proposed to use the NF as a food supplement in the form of capsules,
tablets or powder. The target population for the NF is the general population above 3 years of age.
The maximum proposed daily use levels are 3 g/day for children from 3 years to less than 10 years of
age and 6 g/day thereafter. Taking into account the composition of the NF and the proposed use
levels, the consumption of the NF is not nutritionally disadvantageous. No relevant toxicological
information was provided. The Panel considers that given the qualiﬁed presumption of safety (QPS)
status for production purposes of Yarrowia lipolytica and the fact that the production process of the NF
does not raise safety concerns, no toxicological studies are needed for the safety assessment of the
NF. The Panel concludes that the NF, Yarrowia lipolytica yeast biomass, is safe under the proposed
conditions of use.
© 2019 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
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Summary
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and
Food Allergens (NDA) was asked to deliver a scientiﬁc opinion on Yarrowia lipolytica yeast biomass as
a novel food (NF) pursuant to Regulation (EU) 2015/2283. The assessment of the safety of this NF
follows the methodology set out in the EFSA Guidance on the preparation and presentation of an
application for authorisation of a novel food in the context of Regulation (EU) 2015/2283 and in the
Commission Implementing Regulation (EU) 2017/2469. The assessment is based on the data supplied
in the application and on information submitted by the applicant following EFSA requests for
supplementary information.
The NF is the dried and heat-killed biomass of Yarrowia lipolytica. This yeast species is widespread
in nature and can be found in the environment as well as in a number of foods. Y. lipolytica and
Candida lipolytica are the teleomorph and anamorph names of the same species.
In 2018, the EFSA BIOHAZ Panel assessed Yarrowia lipolytica and recommended this yeast for the
qualiﬁed presumption of safety (QPS) status but only for production purposes, including food and feed
products based on biomass. The qualiﬁcation ‘only for production purposes’ requires the absence of
viable Y. lipolytica cells in the NF.
The production process, basically fermentation followed by washing and drying of the yeast,
includes a heat-killing step of the yeast at high temperatures, resulting in the absence of viable
Y. lipolytica cells in the NF. The Panel considers that the production process is sufﬁciently described
and does not raise safety concerns.
The NF consists primarily of proteins (about 50%) and dietary ﬁbre (about 25%). Information was
also submitted on the fat content, the amino acid proﬁle and the amount of vitamins and minerals in
the NF. The Panel considers that the information provided on the composition of the NF is sufﬁcient
and does not raise safety concerns.
The applicant proposed to use the NF as a food supplement in the form of capsules, tablets or
powder. The target population for the NF is the general population from 3 years of age onwards. The
maximum proposed use levels are 3 g/day for children from 3 years to less than 10 years of age and
6 g/day thereafter.
Taking into account the composition of the NF and the proposed conditions of use, the
consumption of the NF is not nutritionally disadvantageous.
No relevant toxicological information was provided. The Panel considers that given the QPS status
for production purposes of Yarrowia lipolytica and the fact that the production process of the NF does
not raise safety concerns, no toxicological studies are needed for the safety assessment of the NF.
The Panel concludes that the NF, Yarrowia lipolytica yeast biomass, is safe under the proposed
conditions of use.
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1. Introduction
1.1. Background and Terms of Reference as provided by the European
Commission
On 10 April 2017, the company Skotan S.A. submitted a request in accordance with Article 4 of the
Novel Food Regulation (EU) 258/19971 to place on the market Yarrowia lipolytica yeast biomass as a
novel food (NF).
On 26 October 2017, the competent authority of Poland (Institute of Food and Nutrition, Warsaw)
forwarded to the Commission its initial assessment report, which came to the conclusion that Yarrowia
lipolytica yeast biomass meets the criteria for acceptance of a NF deﬁned in Article (3)1 of Regulation
(EU) 258/1997.
Pursuant to Article 35 (1) of Regulation (EU) 2015/22832, any request for placing a novel food on
the market within the Union submitted to a Member State in accordance with Article 4 of Regulation
(EU) 258/1997 and for which the ﬁnal decision has not been taken before 1 January 2018 shall be
treated as an application under Regulation (EU) 2015/2283.
On 20 February 2018, the company Skotan S.A. submitted the same request to the European
Commission in accordance with Article 10 of Regulation (EU) No 2015/2283 to place Yarrowia lipolylica
yeast biomass on the Union market as a novel food.
On 22 June 2018, in accordance with Article 10(3) of Regulation (EU) 2015/2283, the European
Commission asked EFSA to provide a scientiﬁc opinion on Yarrowia lipolytica yeast biomass as a NF.
2. Data and methodologies
2.1. Data
The safety assessment of this NF is based on data supplied in the application and on information
submitted by the applicant following EFSA requests for supplementary information.
Administrative and scientiﬁc requirements for NF applications referred to in Article 10 of Regulation
(EU) 2015/2283 are listed in the Commission Implementing Regulation (EU) 2017/24693.
A common and structured format on the presentation of NF applications is described in the EFSA
guidance on the preparation and presentation of a NF application.4 As indicated in this guidance, it is
the duty of the applicant to provide all of the available (proprietary, conﬁdential and published)
scientiﬁc data, including both data in favour and not in favour, to support the safety of the proposed
NF.
This NF application does not include a request for the protection of proprietary data.
2.2. Methodologies
The assessment follows the methodology set out in the EFSA guidance on NF applications and the
principles described in the relevant existing guidance documents from the EFSA Scientiﬁc Committee.
The legal provisions for the assessment are laid down in Article 11 of Regulation (EU) 2015/2283 and
in Article 7 of the Commission Implementing Regulation (EU) 2017/2469.
This assessment concerns only risks that might be associated with the consumption of the NF
under the proposed conditions of use, and it is not an assessment of the efﬁcacy of the NF with
regard to any claimed beneﬁt.
1 Regulation (EU) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and
novel food ingredients. OJ L 43, 14.2.1997, p. 1–6.
2 Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods, amending Regulation (EU) No 1169/
2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258/97 of the European Parliament and
of the Council and Commission Regulation (EC) No 1852/2001 (2013/0435 (COD). OJ L 327, 11.12.2015, p. 1–22.
3 Commission Implementing Regulation (EU) 2017/2469 of 20 December 2017 laying down administrative and scientiﬁc
requirements for applications referred to in Article 10 of Regulation (EU) 2015/2283 of the European Parliament and of the
Council on novel foods. OJ L 351, 30.12.2017, pp. 64–71.
4 EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), Turck D, Bresson J-L, Burlingame B, Dean T,
Fairweather-Tait S, Heinonen M, Hirsch-Ernst KI, Mangelsdorf I, McArdle H, Naska A, Neuh€auser-Berthold M, Nowicka G,
Pentieva K, Sanz Y, Siani A, Sj€odin A, Stern M, Tome D, Vinceti M, Willatts P, Engel K-H, Marchelli R, P€oting A, Poulsen M,
Salminen S, Schlatter J, Arcella D, Gelbmann W, de Sesmaisons-Lecarre A, Verhagen H and van Loveren H, 2016. Guidance on
the preparation and presentation of an application for authorisation of a novel food in the context of Regulation (EU)
2015/2283. EFSA Journal 2016;14(11):4594, 24 pp. https://doi.org/10.2903/j.efsa.2016.4594
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3. Assessment
3.1. Introduction
The NF which is the subject of the application is the dried and heat-killed biomass of the yeast
Yarrowia lipolytica. The biomass, which is produced by fermentation and which is mostly composed of
proteins and ﬁbre, is proposed to be used as a food supplement in the form of capsules, tablets or
powder. The target population for the NF is the general population from 3 years onwards.
3.2. Identity of the NF
The NF is the dried and heat-killed biomass of the yeast Yarrowia lipolytica.
The taxonomic position of the species was ﬁrst established by Van der Walt and von Arx (1980),
with the following microbiological taxonomy. Kingdom: fungi; sub-kingdom: Dikaryota; division:
Ascomycota; subdivision: Saccharomycotina; class: Saccharomycetes; order: Saccharomycetales;
family: Dipodascaceae; genus: Yarrowia; species: Yarrowia lipolytica.
The species Y. lipolytica can be found in the ‘IndexFungorum’ database5 (record number ID108643).
Y. lipolytica and Candida lipolytica are the teleomorph and anamorph names of the same species.
Y. lipolytica is widespread in nature and it has been isolated from the environment (i.e. soil and
water) as well as from foods high in fat and protein, i.e. ripening meat and dairy products (e.g.
cheddar cheese, Stilton Blue cheese, Armada cheese, Reblochon cheese, Italian-style cheeses, Rokpol)
(B€artschi et al., 1994; Tornadijo et al., 1998; Czajgucka et al., 2003; Ferreira and Viljoen, 2003;
Gkatzionis et al., 2013).
The genome sequence for Y. lipolytica was described by Dujon et al. (2004).
The strain Y. lipolytica A-101 was isolated and identiﬁed in 1975 by the University of Environmental
and Life Sciences in Wrocław/Poland (Department of Biotechnology and Food Microbiology). According
to the information provided, the strain was isolated from soil, it is actively growing on agar (i.e. form
of supply) and it belongs to risk group 1 of microorganisms (WHO, 2004).
The strain was deposited in the Collection of Cultures of the Department of Biotechnology and Food
Microbiology of the University of Wrocław and at the Institute of Agricultural and Food Biotechnology
in Warsaw. The latter institute is a depository body acting in accordance with the Budapest Treaty on
the International Recognition of the Deposit of Microorganisms.
In 2018, Y. lipolytica was assessed by the EFSA Panel on Biological Hazards (BIOHAZ) for its
suitability to be added to the list of qualiﬁed presumption of safety (QPS)-recommended biological
agents intentionally added to food or feed (EFSA BIOHAZ Panel, 2018). For this purpose, the BIOHAZ
Panel considered the identity, the body of knowledge, safety concerns and any potential antimicrobial
resistance of this yeast species. The BIOHAZ Panel noted that several cases of infections by
Y. lipolytica (or its anamorph C. lipolytica) have been described in humans. However, those infections
have occurred in immunocompromised patients with underlying disease and the majority were
catheter-related. Antifungal therapy invariably resulted in clearance of the pathogen. The
Panel concluded that Y. lipolytica is recommended for the QPS status but only for production purposes.
The Panel clariﬁed that the qualiﬁcation ‘for production purpose only’ implies the absence of viable
cells of the production organism in the ﬁnal product and can also be applied for food and feed
products based on microbial biomass (EFSA BIOHAZ Panel, 2018).
3.3. Production process
The NF is produced according to Good Manufacturing Practices (GMP) and Hazard Analysis Critical
Control Points (HACCP) principles.
Flow charts of the manufacturing process and detailed information on the culture conditions and
media have been provided (not shown, conﬁdential).
The ﬁrst step of the manufacturing process consists in the preparation of the Yarrowia lipolytica
yeast inoculum (by grafting the yeast from an agar slant). Proliferation of the yeast is continued in
tanks of increasing capacity using culture media consisting of nutrient sources commonly employed in
fermentation processes. The culture conditions (i.e. temperature, aeration, pH, speed of mixing) are
continuously monitored.
5 http://www.indexfungorum.org/names/names.asp
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After reaching a certain concentration of yeast dry matter, the yeast is harvested, i.e. centrifuged,
rinsed with water, and centrifuged again in order to remove remnant culture medium. Thereafter the
yeast biomass is dried on a drum drier at a speciﬁed temperature for a certain period of time (information
provided) until a moisture content of less than 5% is achieved. During this step the yeast cells are killed.
The Panel notes that in order to monitor the efﬁciency of the heat treatment and to guarantee that there
are no viable Y. lipolytica cells remaining in the dried biomass thereafter, testing for the presence of viable
yeast cells has to be carried out immediately after the heat treatment (see also Speciﬁcations, Table 3).
The Panel also notes that it has to be ensured that no cross-contamination occurs with viable
Y. lipolytica in the ﬁnal steps of the manufacturing process (packaging and storage).
The Panel considers that the production process is sufﬁciently described and does not raise safety
concerns.
3.4. Compositional data
The NF consists primarily of proteins (about 45–55 g/100 g) and dietary ﬁbre (about 25 g/100 g).
The fat content in the NF is about 7–10 g/100 g, the majority being mono- and polyunsaturated fatty
acids.
Information was provided on the accreditation of the laboratories that conducted the analyses
presented in the application.
The applicant provided nutritional information for three batches of the NF (Table 1).
To conﬁrm the microbiological quality of the NF, the applicant provided the results of the testing for
microbiological parameters for eight batches of the NF (Table 2), performed in two distinct testing
facilities.
Table 1: Nutritional analysis of the NF
Parameter (unit)
Batch number/date
‘001’ (2014-12-18) ‘001’ (2015-08-11) ‘1’ (2018-10-16)
Protein (g/100 g) 44.0 55.3 44.4
Dietary ﬁbre (g/100 g) – 24.6 27.2
Saccharides (g/100 g) – < 1.0 < 0.2
Fat (g/100 g) > 7 9 9.9
Saturated fatty acids (FA) 0.7 0.6 1.0
Monounsaturated FA 4.7 4.4 4.7
Polyunsaturated FA 3.6 3.9 3.5
Total ash (%) 9.6 9.4 10.3
Water content (%) 1.5 1.7 4.5
Dry matter content (%) 98.5 98.3 95.5
Sodium content (g/100 g) 1.86 1.98 1.85
FA: fatty acids.
Table 2: Microbiological analysis of the NF
Parameter
Batch numbers
037/15/
01/LH _Z/G
037/15/
02/LH _Z/G
037/15/
03/LH _Z/G
037/15/
04/LH _Z/G
037/15/
05/LH _Z/G
091-13 095-13 099-13
Number of aerobic
microorganisms
(CFU/g)
< 10 < 10 < 10 < 10 < 10 250 100 < 10
Number of yeasts
and moulds (CFU/g)
< 10 < 10 < 10 < 10 < 10 – – –
Number of coliforms
(CFU/g)
< 10 < 10 < 10 < 10 < 10 – – –
Number of coagulase-
positive staphylococci
(CFU/g)
< 10 < 10 < 10 < 10 < 10 – – –
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The NF contains ﬁbre which is mainly composed of beta-glucans, complex polysaccharides that
form part of the cell walls of yeasts and cereals. The applicant submitted a Fourier transformed infra-
red (FTIR) analysis for one sample of the NF, which is compatible with the presence of beta-glucans in
the carbohydrate fraction of the NF.
The applicant also submitted detailed information on the amino acid proﬁle and the amount of
vitamins and minerals in the NF.
Additionally, the applicant provided the analytical results for the content of pesticides in the NF. The
analysed pesticides, i.e. organochlorinated and organophosphate pesticides, pyrethroids and ‘other
pesticides’ were below their limits of quantiﬁcation.
The applicant declared that no genetically modiﬁed organisms are used in the manufacturing
process. In order to support this statement, the applicant provided the results of an analysis for a
number of DNA sequences (i.e. P35s, T-nos, pFMV, npt II, pat, bar, CTP2-CP4-EPSPS) which are
characteristic for genetically modiﬁed organisms. No such sequences were detected in the sample of
the NF analysed.
The Panel considers that the information provided on the composition of the NF is sufﬁcient and
does not raise safety concerns.
3.4.1. Stability
In order to demonstrate the stability of the NF, the applicant performed stability tests with ﬁve
independently produced batches of the NF. The tests for all the batches were carried out at 18–26°C
and at 65% RH. The batches were analysed for their amounts of dry matter, moisture, protein, fat,
ash, and microbiological parameters. After storage of 12 months, an increase of moisture above 5%
was found in the NF, which was considered to be disadvantageous. The other parameters, including
the levels of microorganisms, remained stable over the time of the testing. Accordingly, the
manufacturer set the shelf life to 12 months from the date of manufacture.
The Panel considers that the data provided sufﬁcient information with respect to the stability of the NF.
3.5. Speciﬁcations
The speciﬁcations of the NF are indicated in Table 3.
Parameter
Batch numbers
037/15/
01/LH _Z/G
037/15/
02/LH _Z/G
037/15/
03/LH _Z/G
037/15/
04/LH _Z/G
037/15/
05/LH _Z/G
091-13 095-13 099-13
Salmonella spp.
(in 25 g)
Absent Absent Absent Absent Absent Absent Absent Absent
Number of moulds
(CFU/g)
– – – – – < 10 60 < 10
Presence of anaerobic
spores and sulfate
(IV)- reducing
bacteria (in 0.1 g)
– – – – – Absent Absent Absent
CFU: colony forming units.
Table 3: Speciﬁcations of the NF
Parameter Amount Method
Protein 45–55 g/100 g PN-A-79005-7:1997 or PN-EN ISO 8968-1:2014-03
Dietary ﬁbre 24–30 g/100 g AOAC 985.29 or PN-A-79011-15:1998
Saccharides < 1.0 g/100 g PN-A-74252:1998
Fat 7–10 g/100 g AOAC 922.06 or PN-ISO 1444:2000
Total ash ≤ 12% PN-ISO 928:1999
Water content ≤ 5% PN-EN ISO 665:2004
Dry matter content ≥ 95% PN-EN ISO 665:2004
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The Panel considers that the information provided on the speciﬁcations of the NF is sufﬁcient and
does not raise safety concerns.
3.6. History of use of the NF and/or of its source
Yarrowia lipolytica can naturally be found in a number of foods such as yoghurts, keﬁr and in
various types of cheese (e.g. cheddar cheese, Stilton Blue cheese, Armada cheese, Reblochon cheese,
Italian-style cheeses, Rokpol). Even though not added deliberately to cheese, Y. lipolytica has been
reported to be among the common yeast species therein (Roostita and Fleet, 1996; Welthagen and
Viljoen, 1998; Larpin et al., 2006; Monnet et al., 2010; Larpin-Laborde et al., 2011).
Y. lipolytica has been used for a number of biotechnological applications, owing to its lipolytic and
proteolytic characteristics and its ability to utilise a broad range of substances (e.g. glycerol, ethanol,
n-parafﬁn and alkanes, fatty acids, acetates, animal and vegetable fats) as a carbon source.
In the 1950s, Y. lipolytica was used by British Petroleum Co. (BP) to produce single cell protein
(SCP) for animal feeding (Groenewald et al., 2013).
Mutated and/or genetically engineered strains of Y. lipolytica have obtained Generally Recognized
as Safe (GRAS) status for the production of eicosapentaenoic acid (EPA)-rich triglyceride oil (GRN
000355), erythritol (GRN 000382), rebaudioside A (GRN 000632) and steviol glycosides consisting
primarily of rebaudioside M (GRN 000759), respectively.
Since 2010, Yarrowia lipolytica biomass is used as a feed material in Europe.6
3.7. Proposed uses and use levels and anticipated intake
3.7.1. Target population
The target population for the NF is the general population from 3 years of age onwards.
3.7.2. Proposed uses and use levels
The applicant proposed to use the NF as a food supplement in the form of capsules, tablets or
powder.
For the use of the NF as capsules or tablets, the applicant proposed amounts of 1–2 g/day for
children from 3 years to less than 10 years of age, and 2–3 g/day thereafter.
As concerns the use of the NF in the form of powder (to be measured by the consumer using a
teaspoon or scoop attached to the package), the applicant proposed a daily intake of 1.5–3 g/day for
children from 3 years to less than 10 years of age, and 3–6 g/day thereafter.
The maximum use levels proposed by the applicant, irrespective of the form consumed, are 3 g per
day for children from 3 years to less than 10 years of age, and 6 g per day thereafter.
Parameter Amount Method
Heavy metals
Lead ≤ 3.0 mg/kg PN-EN ISO 17294-2:2006
Cadmium ≤ 1.0 mg/kg PN-EN ISO 17294-2:2006
Mercury ≤ 0.1 mg/kg PN-EN 13804:2013-06 + ASA mercury analyser or
PN-EN 13806:2003
Microbiological
TAMC ≤ 5 9 103 CFU/g PN-EN ISO 4833:2004 + AP1:2005
TYMC ≤ 102 CFU/g PN-ISO 7954:1999
Viable Yarrowia
lipolytica cells(a)
< 10 CFU/g (i.e. limit of detection) PN-ISO 7954:1999
Coliforms ≤ 10 CFU/g PN-ISO 4832:2007
Salmonella spp. Absent in 25 g PN-EN ISO 6579:2003
TAMC: total aerobic microbial count; TYMC: total yeast and mould count; CFU: colony forming units.
(a): To be tested immediately after the heat-treatment step. Measures have to be in place to prevent cross-contamination with
viable Yarrowia lipolytica cells during packaging and/or storage of the NF.
6 http://www.feedmaterialsregister.eu
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3.8. Absorption, distribution, metabolism and excretion (ADME)
No ADME data have been provided on the NF.
3.9. Nutritional information
The applicant provided a nutritional analysis of the NF, which comprises information on the content
of protein, amino acid composition, carbohydrates, ﬁbre, fatty acids, vitamins and minerals in the NF.
The Panel considers that taking into account the composition of the NF and the proposed
conditions of use (up to 3 g/day for children from 3 years to less than 10 years of age and up to
6 g/day thereafter), the consumption of the NF is not nutritionally disadvantageous.
3.10. Toxicological information
The applicant did not submit any relevant toxicological studies performed with the NF.
No human studies with the NF were provided.
3.11. Allergenicity
The applicant pointed out that Y. lipolytica is naturally occurring in foods and that it is not known to
cause allergic reactions in humans.
The Panel notes that Y. lipolytica is not among the yeast species which have been shown to elicit
allergic reactions in humans (Simon-Nobbe et al., 2008).
The Panel considers that given the protein content of the NF (45–55 g/100 g) allergic reactions to
the NF cannot be excluded. However, the Panel considers that the risk is low.
4. Discussion
The NF is the dried and heat-killed biomass of Yarrowia lipolytica, which is a yeast species that is
widespread in nature and which can be found in the environment as well as in foods.
In 2018, the EFSA BIOHAZ Panel assessed Y. lipolytica and recommended this yeast for the QPS
status but only for production purposes, including food and feed products based on biomass. The
qualiﬁcation ‘only for production purposes’ requires that there are no viable Y. lipolytica cells in the
ﬁnal product (e.g. the microbial biomass).
The Panel considers that given the QPS status for production purposes of Yarrowia lipolytica and
the fact that the production process of the NF does not raise safety concerns, no toxicological studies
are needed for the safety assessment of this NF.
5. Conclusions
The Panel concludes that the NF, Yarrowia lipolytica yeast biomass, is safe under the proposed
conditions of use. The target population is the general population above 3 years of age.
Steps taken by EFSA
1) Letter from the European Commission to the European Food Safety Authority with the
request for a scientiﬁc opinion on the safety of Yarrowia lipolytica yeast biomass. Ref. Ares
(2018)3311267, dated 22 June 2018.
2) On 22 June 2018, EFSA received a valid application from the European Commission on
Yarrowia lipolytica yeast biomass as a NF, which was submitted by the company Skotan S.A.,
and the scientiﬁc evaluation procedure started.
3) On 24 July 2018, EFSA requested the applicant to provide additional information to
accompany the application and the scientiﬁc evaluation was suspended.
4) On 23 October 2018, additional information was provided by the applicant and the scientiﬁc
evaluation was restarted.
5) During its meeting on 17 January 2019, the NDA Panel, having evaluated the data, adopted
a scientiﬁc opinion on the safety of Yarrowia lipolytica yeast biomass as a NF pursuant to
Regulation (EU) 2015/2283.
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Abbreviations
ADME absorption, distribution, metabolism and excretion
BIOHAZ Biological Hazards
CFU colony forming units
EPA eicosapentaenoic acid
FA fatty acids
FTIR analysis Fourier transformed infra-red analysis
GMP Good Manufacturing Practices
GRAS Generally Recognized as Safe
HACCP Hazard Analysis Critical Control Points
NDA Nutrition, Novel Foods and Food Allergens
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NF novel food
QPS qualiﬁed presumption of safety
RH residual humidity
SCP single cell protein
TAMC total aerobic microbial count
TYMC total yeast and mould count
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